Effect of selective cyclooxygenase-2 inhibitors on heart rate in healthy young men

American Journal of Cardiology

Volumn 95, Issue 12, 2005, Pages 1531-1532

  Lamprecht, Christoph ^b   Werner, Ulrike ^b   Werner, Dierk ^b   Schaefer, Simon ^b   Renner, Bertold ^b   Fromm, Martin ^b   Brune, Kay ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; METOPROLOL; PROSTAGLANDIN; ROFECOXIB; VALDECOXIB;

ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HEART FUNCTION; HEART PROTECTION; HEART RATE; HUMAN; LONG TERM CARE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUDDEN DEATH;

ADRENERGIC BETA-ANTAGONISTS; CYCLOOXYGENASE INHIBITORS; DRUG COMBINATIONS; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY, AMBULATORY; HEART; HEART RATE; HUMANS; ISOXAZOLES; MALE; METOPROLOL; PYRIMIDINES; REFERENCE VALUES; SULFADIMETHOXINE; SULFONAMIDES;

EID: 20444461667     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.02.033     Document Type: Article

References (7)

1. C. Bombardier, L. Laine, A. Reicin, D. Shapiro, R. Burgos-Vargas, B. Davis, R. Day, M.B. Ferraz, C.J. Hawkey, M.C. Hochberg, T.K. Kvien, T.J. Schnitzer VIGOR Study Group Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis VIGOR Study Group N Engl J Med 343 2000 1520 1528
2. D.J. Graham, D. Campen, C. Cheetham, R. Hui, M. Spence, W.A. Ray Risk of acute cardiac events among patients treated with cyclooxygenase-2 selective and non-selective non-steroidal anti-inflammatory drugs nested case-control study Lancet 365 2005 449 451
3. R. Bolli, K. Shinmura, X.L. Tang, E. Kodani, Y.T. Xuan, Y. Guo, B. Dawn Discovery of a new function of cyclooxygenase (COX)-2 COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning Cardiovasc Res 55 2002 506 519
4. J.K. Hennan, J. Huang, T.D. Barrett, E.M. Driscoll, D.E. Willens, A.M. Park, L.J. Crofford, B.R. Lucchesi Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries Circulation 104 2001 820 825
5. M.J. Wacker, R.N. Tehrani, R.L. Smoot, J.A. Orr Thromboxane A (2) mimetic evokes a bradycardia mediated by stimulation of cardiac vagal afferent nerves Am J Physiol Heart Circ Physiol 282 2002 H482 H490
6. U. Werner, D. Werner, T. Rau, M. Fromm, B. Hinz, K. Brune Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humans Clin Pharmacol Ther 74 2003 130 137
7. G.A. FitzGerald, C. Patrono The coxibs, selective inhibitors of cyclooxygenase-2 N Engl J Med 345 2001 433 442